Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sight Sciences (SGHT) Other financing activities (2020 - 2025)

Sight Sciences (SGHT) has 6 years of Other financing activities data on record, last reported at $2.5 million in Q4 2025.

  • For Q4 2025, Other financing activities changed N/A year-over-year to $2.5 million; the TTM value through Dec 2025 reached $13.1 million, up 187.15%, while the annual FY2025 figure was $13.1 million, 5384.87% up from the prior year.
  • Other financing activities reached $2.5 million in Q4 2025 per SGHT's latest filing, up from $2.4 million in the prior quarter.
  • Across five years, Other financing activities topped out at $4.5 million in Q1 2024 and bottomed at -$4.3 million in Q2 2024.
  • Average Other financing activities over 5 years is $2.5 million, with a median of $3.1 million recorded in 2022.
  • Peak YoY movement for Other financing activities: skyrocketed 1332.31% in 2021, then tumbled 43.8% in 2025.
  • A 5-year view of Other financing activities shows it stood at $2.0 million in 2021, then soared by 63.66% to $3.2 million in 2022, then increased by 19.23% to $3.9 million in 2023, then grew by 11.72% to $4.3 million in 2024, then plummeted by 40.85% to $2.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other financing activities were $2.5 million in Q4 2025, $2.4 million in Q3 2025, and $3.8 million in Q2 2025.